Last edition
News about "Pint Pharma"
Pint Pharma Gets ANVISA Approval of BESREMi for Polycythemia Vera
Polycythemia Vera (PV) is a rare, chronic, debilitating, and potentially fatal myeloproliferative neoplasm, originating from a disease-initiating stem cell in the bone marrow.
Pint Pharma | 21/03/2025 | By Aishwarya
Pint Pharma Announces Approval of ORLADEYO in Peru
Pint Pharma has announced that the General Directorate of Medicines Supplies and Drugs (DIGEMID) in Peru has announced the approval of ORLADEYO (berotralstat) for prophylaxis of hereditary angioedema (HAE) attacks in adults and children 12 years and older.
Pint Pharma | 10/07/2024 | By Aishwarya | 241
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy